Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.36 AUD | -7.69% |
|
+20.00% | +105.71% |
06-26 | Cleo Diagnostics Secures US FDA Feedback for Ovarian Cancer Test | MT |
06-23 | 7,500,000 Ordinary Shares of Cleo Diagnostics Ltd are subject to a Lock-Up Agreement Ending on 23-JUN-2024. | CI |
End-of-day quotes
Sector Diagnostic & Testing Substances
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
33.36M | - | - | - | - | - | |
11.38B | ||||||
6.83B | - | - | - | - | - | |
5.44B | - | - | ||||
5.52B | ||||||
3.62B | - | - | - | - | - |
- Stock Market
- Equities
- COV Stock
- Charts Cleo Diagnostics Ltd
- Sector Chart